This course has expired. View available courses.
Endocrinology
Kidney Disease in Type 2 Diabetes: Optimizing Renal Protection
Slowing the development and progression of CKD remains an unmet clinical need in patients with T2D. This program supports pharmacists in ensuring their up-to-date knowledge of pharmacological options that have demonstrated nephroprotective effects in patients with T2D and CKD.
The efficacy, safety, and dosing of these nephroprotective medications will be illustrated through case-based learning, to increase pharmacists’ confidence in identifying patients in community practice who might benefit and recommending this class of medication.
DURATION
45 mins
PROFESSION
Pharmacy
# OF CREDITS
0.75
ACCREDITATION
CCCEP
EXPIRY DATE
2021-08-17
Slowing the development and progression of CKD remains an unmet clinical need in patients with T2D. This program supports pharmacists in ensuring their up-to-date knowledge of pharmacological options that have demonstrated nephroprotective effects in patients with T2D and CKD.
The efficacy, safety, and dosing of these nephroprotective medications will be illustrated through case-based learning, to increase pharmacists’ confidence in identifying patients in community practice who might benefit and recommending this class of medication.
Faculty
Lori Berard, Nurse Consultant, CDE
Rick Siemens, BSc. Pharm, CDE., CPT
Jessie Haggai, BSc.Pharm, CDE., CPT
John Papastergiou, BSc. Pharm
Learning objectives
On completion of this program, participants should be able to:
- Describe CKD and the available treatment options to optimize renal protection
- Review the efficacy and safety of SGLT2 inhibitors in patients with T2D and CKD
- Highlight the role of the community pharmacist
in managing patients with CKD